Yesterday in Dallas federal court, Carter Albrecht's parents, Ken and Judy, finally sued Pfizer, claiming that its smoking-cessation drug Chantix played a "direct and proximate" role in Carter's shooting death almost two years ago to the day. The Albrechts have long considered suing Pfizer, but Ken waited until the Food and Drug Administration took action of its own, which it did in July when it announced that Chantix packaging will now include a "mental health events" warning.
Albrecht tells Unfair Park that the suit -- which asks for "compensatory damages for the described injuries and losses with respect to each cause of action" and "funeral and burial expenses," among other requests for relief -- also serves another purpose. "When the FDA backs off, we can continue to remind Pfizer they have to keep the public informed of the risks associated with this drug," he says.
The Albrechts' lawsuit -- which Tim Rogers posted earlier today and which is available in full after the jump -- is but one of many Chantix suits piling up over the last year. In fact there are so many scattered throughout the courts, especially following the FDA's July announcement, that this month there's a hearing to see whether they should be consolidated.
Ken also knows that should this go to trial, as the Albrechts have requested, Pfizer's attorneys will remind the jury, over and over again, that Carter's blood alcohol level was 0.29 the night he died, three times the legal driving limit. By the time this is over, Ken says, Pfizer will put Carter on trial as well.
"Absolutely," he says. "Absolutely. Yes, it's going to be difficult, I am sure. We didn't go into this blindly. They have the best attorneys in the world, the pharmaceutical companies, because people die when they take their drugs. So we'll see. It'll be a long, drawn-out affair. ... Because when people die from your product, you have to dig in your heels. The only alternative is to admit that you screwed up."
Keep the Dallas Observer Free... Since we started the Dallas Observer, it has been defined as the free, independent voice of Dallas, and we would like to keep it that way. Offering our readers free access to incisive coverage of local news, food and culture. Producing stories on everything from political scandals to the hottest new bands, with gutsy reporting, stylish writing, and staffers who've won everything from the Society of Professional Journalists' Sigma Delta Chi feature-writing award to the Casey Medal for Meritorious Journalism. But with local journalism's existence under siege and advertising revenue setbacks having a larger impact, it is important now more than ever for us to rally support behind funding our local journalism. You can help by participating in our "I Support" membership program, allowing us to keep covering Dallas with no paywalls.